Suchergebnisse - "Papandreou, Christopher"

PubPharm (119)

61

Cross-sectional associations of objectively-measured sleep characteristics with obesity and type 2 diabetes in the PREDIMED-Plus trial

enthalten in: Sleep | 2018

von Rosique-Esteban, N. | Papandreou, C. | Romaguera, D. | +31

62

Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial : A Case-Cohort Study

enthalten in: Clinical chemistry | 2018

von Yu, E. | Papandreou, C. | Ruiz-Canela, M. | +18

CommentIn: Clin Chem. 2018 Oct;64(10):1541-1542. - PMID 30087141

63

Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes : case-cohort study within the PREDIMED Trial

enthalten in: Diabetologia | 2018

von Ruiz-Canela, M. | Guasch-Ferré, M. | Toledo, E. | +22

64

Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial

enthalten in: The American journal of clinical nutrition | 2018

von Papandreou, C. | Bulló, M. | Zheng, Y. | +19

65

Legume consumption is inversely associated with type 2 diabetes incidence in adults : A prospective assessment from the PREDIMED study

enthalten in: Clinical nutrition (Edinburgh, Scotland) | 2018

von Becerra-Tomás, N. | Díaz-López, A. | Rosique-Esteban, N. | +114

66

Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial

enthalten in: Diabetologia | 2018

von Ruiz-Canela, M. | Guasch-Ferré, M. | Toledo, E. | +22

67

Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial

enthalten in: Diabetologia | 2018

von Ruiz-Canela, M. | Guasch-Ferré, M. | Toledo, E. | +22

68

Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial

enthalten in: Diabetologia | 2018

von Ruiz-Canela, M. | Guasch-Ferré, M. | Toledo, E. | +22

69

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

enthalten in: Nutrition & metabolism | 2017

von Papandreou, C. | Bullò, M. | Tinahones, F. | +7

70

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

enthalten in: Nutrition & metabolism | 2017

von Papandreou, C. | Bullò, M. | Tinahones, F. | +7